0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

CLINICAL RESULTS WITH MEASLES STREPTOCOCCUS TOXIN AND ANTITOXIN

N. S. FERRY, M.D.; E. J. GORDON, M.D.; F. W. MUNRO, M.B.; A. H. STEELE, M.D.; L. W. FISHER, B.S.
JAMA. 1928;91(17):1277-1280. doi:10.1001/jama.1928.02700170041012.
Text Size: A A A
Published online

In March, 1926, Ferry and Fisher,1 in a preliminary report, described the preparation of measles toxin and antitoxin from a green-producing streptococcus, which they called Streptococcus morbilli, isolated by them from blood in early cases of measles. In 1927, Ferry2 described in detail later experiments with this organism and its toxin and antitoxin, on both man and the animal, and in a paper, soon to be published, Ferry and Noble3 have compared this streptococcus with other green-producing micrococci by means of cultural and serologic reactions.

At this time a condensed report is presented of the clinical work recently conducted with measles antitoxin at the Children's Hospital and at Herman Kiefer Hospital, Detroit, and with measles toxin and antitoxin at the Children's Convalescent Home, Farmington and the Wayne County Training School, Northville.

It should be mentioned that, previous to the experiments included in this report, measles antitoxin was

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();